Scientist.com to Host Expert Webinar on New Approach Methodologies for Drug Discovery and Development
核心洞察
Scientist.com (搜索) will host a virtual expert webinar on New Approach Methodologies (NAMs) on June 17, 2026, featuring leaders from BioIVT (搜索), HUB Organoids (搜索), and Cyprotex (搜索).
The webinar will cover practical strategies for applying human-relevant models, organoids, and AI-enabled transcriptomics to improve translational relevance in drug discovery.
Dr. Kevin Lustig, CEO of Scientist.com (搜索), emphasized that NAMs are increasingly important for predictive, scalable, and human-relevant research approaches.
Scientist.com (搜索), the life science industry's leading AI-enabled research orchestration platform and digital marketplace, has announced an upcoming expert webinar titled "New Approach Methodologies (NAMs): Key Considerations and Applications," scheduled for Wednesday, June 17, 2026, at 8:00 a.m. PT. The virtual event will convene scientific leaders from BioIVT (搜索), HUB Organoids (搜索), and Cyprotex (搜索) to explore how NAMs are being deployed to enhance translational relevance, generate more human-relevant data, and support the replacement, reduction, and refinement of animal testing across drug discovery and development.
"NAMs are becoming increasingly important as the industry looks for more predictive, scalable and human-relevant approaches to research," said Kevin Lustig, PhD, Founder and CEO of Scientist.com (搜索). "This webinar reflects Scientist.com's commitment to helping scientists understand, evaluate and access the innovative technologies shaping the future of drug development."
Three Technical Presentations from Industry Experts
The webinar will feature three focused technical presentations addressing distinct aspects of NAM implementation across research workflows.
Dr. Courtney Noah, VP of Scientific Affairs at BioIVT (搜索), will deliver a presentation titled "Crucial Starting Material Considerations for NAM Success," examining the biological starting materials and baseline variables that can influence the outcomes of NAM-based studies.
Dr. René Overmeer, Principal Scientist at HUB Organoids (搜索), part of Merck KGaA, will present "Miniaturizing Organoid Screening for Commercial R&D," discussing approaches for scaling and miniaturizing organoid-based screening to meet the demands of commercial research and development.
Dr. Paul Walker, VP and Head of Toxicology and Innovation Efficiency at Cyprotex (搜索), will share advances in high-throughput transcriptomic profiling in his talk, "Predicting Multi-Organ Toxicity Early Using AI-Enabled Transcriptomic Profiling in Human Models."
Interactive Panel and Q&A Session
Beyond the individual presentations, the session will include a live panel discussion and audience Q&A, providing attendees the opportunity to submit technical questions directly to the presenters. This interactive format is designed to foster deeper engagement with the practical challenges and opportunities associated with adopting NAMs in pharmaceutical R&D.
Registration and Platform Context
The webinar is open for registration through Scientist.com (搜索)'s website. Scientist.com operates as an AI-enabled R&D orchestration platform and online marketplace, powering secure, private marketplaces for many of the world's largest pharmaceutical companies and hundreds of biotechnology firms. The platform streamlines access to complex research services, products, technologies, and data, while supporting compliance through integrated pre-project reviews, approvals, and oversight. The company is headquartered in Solana Beach, California, with team members supporting customers and suppliers worldwide.